Finanza

Discussioni Tecnici Stagionalità

EBITDA su PAR DRUGS AND CHEM LTD.

Dati annuali

2017

2018

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪60,00 M‬‬

‪‪120,00 M‬‬

‪‪180,00 M‬‬

‪‪240,00 M‬‬

Periodo

Valore

Variazione

Variazione %

TTM

‪‪231,66 M‬‬

+‪‪4,09 M‬‬

+‪1,80‬%

2023

‪‪227,57 M‬‬

+‪‪49,85 M‬‬

+‪28,05‬%

2022

‪‪177,72 M‬‬

+‪‪18,21 M‬‬

+‪11,42‬%

2021

‪‪159,51 M‬‬

‪‪−412,25 K‬‬

‪−0,26‬%

2020

‪‪159,92 M‬‬

+‪‪66,01 M‬‬

+‪70,30‬%

2019

‪‪93,91 M‬‬

+‪‪11,66 M‬‬

+‪14,18‬%

2018

2017

Dati trimestrali

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪30,00 M‬‬

‪‪60,00 M‬‬

‪‪90,00 M‬‬

‪‪120,00 M‬‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

‪‪14,29 M‬‬

‪‪−99,79 M‬‬

‪−87,47‬%

Q2 '24

‪‪114,08 M‬‬

+‪‪71,73 M‬‬

+‪169,39‬%

Q1 '24

‪‪42,35 M‬‬

‪‪−18,59 M‬‬

‪−30,51‬%

Q4 '23

‪‪60,94 M‬‬

+‪‪8,65 M‬‬

+‪16,54‬%

Q3 '23

‪‪52,29 M‬‬

‪‪−21,34 M‬‬

‪−28,98‬%

Q2 '23

‪‪73,63 M‬‬

+‪‪32,30 M‬‬

+‪78,18‬%

Q1 '23

‪‪41,32 M‬‬

‪‪−12,51 M‬‬

‪−23,24‬%

Q4 '22

‪‪53,83 M‬‬

+‪‪21,52 M‬‬

+‪66,62‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21